• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Stimulation of adenosine A2a receptors in the rat striatum induces catalepsy that is reversed by antagonists of N-methyl-D-aspartate receptors.

作者信息

Hauber W, Münkle M

机构信息

Department of Animal Physiology, University of Stuttgart, Germany.

出版信息

Neurosci Lett. 1995 Aug 25;196(3):205-8. doi: 10.1016/0304-3940(95)11871-s.

DOI:10.1016/0304-3940(95)11871-s
PMID:7501284
Abstract

Bilateral infusion of the selective adenosine A2a agonist CGS 21680C (1 microgram per side) into the anterodorsal striatum of rats produced profound catalepsy. Intraperitoneal coadministration of the non-competitive N-methyl-D-aspartate (NMDA) antagonist dizocilpine (0.16 mg/kg) or the competitive NMDA antagonist CGP 37849 (4 mg/kg) completely reversed CGS 21680C-induced catalepsy, while lower doses of both NMDA antagonists induced no or only weak anticataleptic effects. The adenosine A2a receptor localization to striatopallidal neurons suggests that a selective activation of the striatopallidal efferent pathway is involved in the expression of catalepsy induced by intrastriatal infusion of CGS 21680C. In addition, striatopallidal neurons seem to be an important neuronal substrate of the anticataleptic effects of NMDA antagonists.

摘要

相似文献

1
Stimulation of adenosine A2a receptors in the rat striatum induces catalepsy that is reversed by antagonists of N-methyl-D-aspartate receptors.
Neurosci Lett. 1995 Aug 25;196(3):205-8. doi: 10.1016/0304-3940(95)11871-s.
2
MK 801 reverses haloperidol-induced catalepsy from both striatal and extrastriatal sites in the rat brain.MK801可逆转大鼠脑内纹状体和纹状体以外部位由氟哌啶醇诱发的僵住症。
Eur J Pharmacol. 1997 Aug 6;332(2):153-60. doi: 10.1016/s0014-2999(97)01078-9.
3
The adenosine receptor antagonist theophylline induces a monoamine-dependent increase of the anticataleptic effects of NMDA receptor antagonists.
Naunyn Schmiedebergs Arch Pharmacol. 1996 Jul;354(2):179-86. doi: 10.1007/BF00178718.
4
Combined treatment with NMDA antagonist, CGP 37849, and sigma receptor agonists, SA4503 or DTG, decreases the neuroleptic-induced catalepsy in rats.NMDA拮抗剂CGP 37849与σ受体激动剂SA4503或DTG联合治疗可减轻大鼠的抗精神病药物诱导的僵住症。
Pol J Pharmacol. 2000 Jul-Aug;52(4):313-6.
5
A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.竞争性和非竞争性N-甲基-D-天冬氨酸受体拮抗剂体内神经保护特性的比较分析:对兴奋毒性变性过程及其治疗的意义。
Neuroscience. 1993 Aug;55(4):883-92. doi: 10.1016/0306-4522(93)90305-y.
6
Morphine-induced catalepsy is augmented by NMDA receptor antagonists, but is partially attenuated by an AMPA receptor antagonist.
Eur J Pharmacol. 1996 Jan 11;295(2-3):137-46. doi: 10.1016/0014-2999(95)00667-2.
7
The AMPA receptor antagonist GYKI 52466 reverses the anti-cataleptic effects of the competitive NMDA receptor antagonist CGP 37849.AMPA受体拮抗剂GYKI 52466可逆转竞争性NMDA受体拮抗剂CGP 37849的抗僵住效应。
Eur J Pharmacol. 1994 May 2;256(3):339-42. doi: 10.1016/0014-2999(94)90561-4.
8
The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior.
J Neural Transm Gen Sect. 1992;87(1):23-35. doi: 10.1007/BF01253108.
9
The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine.非NMDA谷氨酸受体拮抗剂GYKI 52466可对抗NMDA拮抗剂地佐环平诱导的运动刺激和抗僵住活性。
Naunyn Schmiedebergs Arch Pharmacol. 1993 Nov;348(5):486-90. doi: 10.1007/BF00173207.
10
Role of adenosine and N-methyl-D-aspartate receptors in mediating haloperidol-induced gene expression and catalepsy.腺苷和N-甲基-D-天冬氨酸受体在介导氟哌啶醇诱导的基因表达和僵住症中的作用。
J Pharmacol Exp Ther. 1999 Nov;291(2):531-7.

引用本文的文献

1
Incarvillateine produces antinociceptive and motor suppressive effects via adenosine receptor activation.茵芋碱通过激活腺苷受体产生镇痛和运动抑制作用。
PLoS One. 2019 Jun 25;14(6):e0218619. doi: 10.1371/journal.pone.0218619. eCollection 2019.
2
The effect of the adenosine A(2A) antagonist KW-6002 on motor and motivational processes in the rat.腺苷A(2A)拮抗剂KW-6002对大鼠运动及动机行为过程的影响。
Psychopharmacology (Berl). 2006 Jan;184(1):46-55. doi: 10.1007/s00213-005-0240-z. Epub 2005 Dec 13.
3
Neuroleptic-induced catalepsy: electrophysiological mechanisms of functional recovery induced by high-frequency stimulation of the subthalamic nucleus.
抗精神病药物所致僵住症:高频刺激丘脑底核诱导功能恢复的电生理机制
J Neurosci. 2005 Aug 17;25(33):7687-96. doi: 10.1523/JNEUROSCI.1056-05.2005.
4
Influence of CGS 21680, a selective adenosine A(2A) agonist, on the phencyclidine-induced sensorimotor gating deficit and motor behaviour in rats.选择性腺苷A(2A)激动剂CGS 21680对苯环利定诱导的大鼠感觉运动门控缺陷及运动行为的影响。
Psychopharmacology (Berl). 2003 Jul;168(3):299-306. doi: 10.1007/s00213-003-1439-5. Epub 2003 Apr 9.
5
A common signaling pathway for striatal NMDA and adenosine A2a receptors: implications for the treatment of Parkinson's disease.纹状体N-甲基-D-天冬氨酸(NMDA)受体与腺苷A2a受体的共同信号通路:对帕金森病治疗的启示
J Neurosci. 2000 Oct 15;20(20):7782-9. doi: 10.1523/JNEUROSCI.20-20-07782.2000.
6
The adenosine receptor antagonist theophylline induces a monoamine-dependent increase of the anticataleptic effects of NMDA receptor antagonists.
Naunyn Schmiedebergs Arch Pharmacol. 1996 Jul;354(2):179-86. doi: 10.1007/BF00178718.